eedleless Connectors in Dialysis

Not Applicable

Completed

• Conditions: Haemodialysis patients; Renal and Urogenital - Kidney disease

• Registration Number: ACTRN12611001193965
• Lead Sponsor: Eastern Health Integrated Renal Service

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-11-17
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Patient has a permcath in situ being used for haemodialysis (or other renal treatment such as plasmaphoresis)

Exclusion Criteria

Inability to give informed consent.
Patient has a current, active infection.
Permcath not expected to be in situ for longer than 1 month.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improved patient experience with reduced connection/disconnection times. A Likert scale will be used to assess patient satisfaction.[After two months];Improved staff experience with reduced connection/disconnection times. A Likert scale will be used to assess staff satisfaction.[After two months];No difference in Catheter Related Blood Stream Infections (CR BSI). Microbiology and pathology results from patients medical notes will be recorded.[After two months]

Secondary Outcome Measures

Name	Time	Method
il[Nil]